Novatek International is pleased to announce that KRS Global Biotechnology has chosen Nova-LIMS for use at their FL, USA site.
KRS’ strategic decision to utilize the building block-like components of Novatek’s Nova-LIMS for Raw Materials, Finished Product and Stability study management reinforces our mandate for organizations in the life sciences industry to build their solution, with the flexibility to grow at their needs and implement at their pace.
We are pleased to welcome KRS to our family of clientele and we look forward to supporting their Quality and Data Compliance needs for years to come.
About KRS Global Bitechnology
KRS is an industry leading 503b Outsourcing Facility that provides sterile and non-sterile compounding services to patients, surgery centers, ophthalmology clinics and hospitals nationwide. KRS is committed to staying the unsurpassed provider of sterile intravenous admixture compounding services and to developing quality processes that facilitates the highest level of safety for patients who are recipients of intravenous, parenteral, enteral or oral preparations.